GZMB and urothelial carcinoma: Studies identified GZMB expression in urothelial carcinoma (UC) tissues, revealing statistically significant correlations between its expression levels and tumor grading, and demonstrating that GZMB remodeled the ECM in UC by cleaving desmoglein, thus enhancing tumor invasive capabilities (57, 65).